Member Info for Mongrels3

Interesting feature on Vare in the Propel newsletter

There is nothing holding us back with Coppa. We've got a good model and it’s converting well and resonating well. There’s plenty of choice for us out there at the moment. We hope to be telling people about expansion in Coppa Club pretty soon. Conversations are in play.”

Great to see VARE with some expansion plans. Very strong management team here in my opinion.

Good to see a little bit happening here. Feels like positive messages around brand focus and targeted M&A

Great results again yesterday and 9% LFL's over the Christmas period beats any LFL's I've seen in the sector for the same period.

Any other views out there?

Really good set of results this morning.

Very big buy from the founder at the end of last week. Are there any views on Vare out there?? As a total punt, I have bought 25,000 this morning. Mainly because the management here have top class credentials. Looks like they will update the market on/around 1st November

Liberum has kicked-off coverage of On The Beach at a 'buy', setting a 560p target price for the online travel operator's shares in the process.

On The Beach shares mispriced,says Peel Hunt.Target 300p

Yesterday’s full-year trading update from On The Beach (OTB) proved to Peel Hunt that shares in the package holiday group are ‘mispriced’.

Analyst Ivor Jones reiterated his ‘buy’ recommendation and target price of 300p on the Citywire Elite Companies + rated stock, which was trading at 120p on Wednesday.

He said the group has ‘invested heavily in growth in the first half 2023 and it has paid off’, with estimates that summer booking will be 11% ahead year-on-year, and winter 26% ahead, more than the 21% reported by peer Jet2 (JET2).

Jones’ 2023 profit before tax forecasts remain at the top of range, and he predicts earnings growth of 40% in 2024, which he said is ‘stretching but achievable’.

‘We estimate On The Beach will have £73m of cash at year-end and no debt,’ he said. ‘It can use that cash to drive growth in full-year 2024 as it did in full-year 2023. Investors can now be confident in the payback.’

Jefferies raises Spire Healthcare to 'buy' (hold) - price target 250 (240) pence

Good results from FGP this morning. Hopefully a read across to NEX

That is a really good spot. It's amazing what you can pick up through LinkedIn and Twitter.

LY will be last year.

In other words, we smashed our target and the same period last year.

For November...

'Household appliances, footwear and furniture saw positive sales growth both in store and online as consumers sought out good deals on designer items and started to prepare for Christmas gatherings at home'

Spire raised to buy at Peel Hunt

Taken from KPMG’s retail sales analysis this morning.

Once again, clothing and footwear came to the rescue of the high street, and back to school purchasing was a driver in retail growth figures, with sales of children’s shoes up over 15%.

https://home.kpmg/uk/en/home/insights/2022/06/a-perspective-on-the-brc-kpmg-retail-sales-monitor-may-2022.html

There was better news though for clothing, footwear and accessories sales, with both in-store and online purchasing driven up by the approach of the summer season and the promise of outdoor events and travel firmly on many consumers’ radars

From the Tesco prelims today. Hopefully a read across in to SHOE.

'Non-food sales growth was particularly strong this year, driven mainly by Clothing +19.4%'

and another from Barclays today - 3.10

JPMorgan raises Spire Healthcare price target to 347 (296) pence - 'overweight'

Director buys and Tosca fund adding last Friday. From memory, Tosca were one of the shareholders who rejected the takeover last year.

https://www.reuters.com/world/uk/uk-retail-sales-grow-faster-than-expected-january-2022-02-18/